治験レーダーAI | ||
|---|---|---|
治験 NCT04879251 (ICOVdia)（対象：糖尿病、COVID-19）は完了です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。 | ||
フィルター基準に一致する試験が1件見つかりました
タイル表示
The Impact of the COVID-19 Pandemic on Cardiovascular Risk Factors in Patients With Diabetes (ICOVdia) 1,000
治験（臨床試験）の詳細は主に英語で提供されていますが、治験レーダーAIがサポートします！「治験解説」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT04879251 (ICOVdia) は 観察研究 臨床試験 で、糖尿病、COVID-19 を対象とした研究でした。現在は 完了 です。2021年4月26日 に開始し、1,000 名の参加者 が参加しました。この試験は University Hospital Ostrava によって主導され、2022年8月31日 に完了しました。ClinicalTrials.gov からの最新更新日は 2022年12月7日 です。
概要
The objective of this study is to compare cardiovascular risk factors in patients with diabetes before the start of the pandemic of the COVID 19 (time 1 - T1), after 1 year (time 2 - T2) and 2 years (time 3 - T3) duration. In patients with all types of diabetes, the investigators will compare the value of blood pressure, LDL cholesterol, BMI (body mass index) and glycated haemoglobin in T1, T2 and T3 during outpatien...もっと見る
詳細説明
Diabetes mellitus (DM) is one of the major risk factors of cardiovascular diseases (CVDs), which are the leading cause of death globally. To reduce overall cardiovascular risk in patients with diabetes, it is necessary, in addition to compensation of diabetes, to reduce other risk factors of cardiovascular diseases. The COVIDs 19 (coronavirus disease of 2019) pandemic has in addition to direct influence (fever, pneum...もっと見る
公式タイトル
The Impact of the COVID-19 Pandemic on Cardiovascular Risk Factors in Patients With Diabetes.
疾患名
糖尿病COVID-19その他の研究識別子
- ICOVdia
- 3/IK-FNO/2021
NCT番号
開始日
2021-04-26
最終更新日
2022-12-07
終了予定日
2022-08-31
目標参加者数
1,000
試験の種類
観察研究
状況
完了
キーワード
Diabetes Mellitus
COVID 19
LDL hyperlipoproteinemia
COVID 19
LDL hyperlipoproteinemia
群（アーム）／介入
| 参加グループ/群 | 介入/治療法 |
|---|---|
該当なし | 介入なし No intervention |
主要評価項目
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Number of patients with diabetes who have a worse glycated hemoglobin value (Change from baseline after 1 and 2 year of COVID 19 pandemic) | The investigators compare the value of glycated hemoglobin before the start of the COVID 19 pandemic and change from baseline after one year of the pandemic in each participant with diabetes. | Baseline values - before the start of COVID 19 pandemic (1.9.2019 - 1.3.2020)- change from baseline after 1 year 1.4. - 31.7. 2020 and after 2 years (1.4.2021-31.7.2022) |
Number of patients with diabetes who have a worse LDL cholesterol value (Change from baseline after 1 and 2 year of COVID 19 pandemic) | The investigators compare the value of LDL cholesterol before the start of the COVID 19 pandemic and change from baseline after one year of the pandemic in each participant with diabetes. | Baseline values - before the start of COVID 19 pandemic (1.9.2019 - 1.3.2020)- change from baseline after 1 year 1.4. - 31.7. 2020 and after 2 years (1.4.2021-31.7.2022) |
Number of patients with diabetes who have a higher BMI value (Change from baseline after 1 and 2 year of COVID 19 pandemic) | The investigators compare the value of BMI before the start of the COVID 19 pandemic and change from baseline after one year of the pandemic in each participant with diabetes. | Baseline values - before the start of COVID 19 pandemic (1.9.2019 - 1.3.2020)- change from baseline after 1 year 1.4. - 31.7. 2020 and after 2 years (1.4.2021-31.7.2022) |
Number of patients with diabetes who have a higher BP (blood pressure) value (Change from baseline after 1 and 2 year of COVID 19 pandemic) | The investigators compare the value of blood pressure before the start of the COVID 19 pandemic and change from baseline after one year of the pandemic in each participant with diabetes. | Baseline values - before the start of COVID 19 pandemic (1.9.2019 - 1.3.2020)- change from baseline after 1 year 1.4. - 31.7. 2020 and after 2 years (1.4.2021-31.7.2022) |
適格基準
対象年齢
成人, 高齢者
試験の最低年齢
18 Years
対象性別
全て
- Age ≥ 18
- Diabetes mellitus of any type
- Planned visit to the outpatient diabetic clinic between 1.4. and 31.7.2021 - T2 (creation of the study group) - University hospital Ostrava, Czech Republic
- Known values of blood pressure, glycated haemoglobin, LDL cholesterol and BMI before the start of the pandemic (1.3.2020), not older than 6 months and no later than 31.3.2020.
- Signed consent to the use of anonymous data for scientific purposes and publications.
- failure to meet the criteria for inclusion
University Hospital Ostrava連絡先情報がありません。
1 1カ国の場所
University Hospital Ostrava, Ostrava, 70852, Czechia